NMANX Mutual Fund

NAV$15.67

Fund Essentials - as of Feb 28, 2026

Net Assets
$461M
Expense Ratio
0.83%
Dividend Yield (Current)
20.63%
Holdings
76
Inception Date
Mar 1, 1979
Fund Family
Neuberger Berman
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+9.77%
1 Year-12.53%
3 Year+9.43%
5 Year+1.66%
10 Year+10.84%

Asset Allocation

Stocks: 98.23%
Cash: 1.78%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
CORCencora Inc4.16%
HLTHilton Worldwide Holdings, Inc.3.77%
HWMHowmet Aerospace Inc.3.71%
VRTVertiv Group Corp3.68%
0I1W:LRRoyal Caribbean Cruises Ltd.3.23%
Top 10 Concentration: 31.36%Report Date: Feb 28, 2026
Download all 76 holdings for NMANX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
20.63%
Frequency
Annually
Latest Distribution
$3.13
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how NMANX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

NMANX Mutual Fund Overview

NMANX Mutual Fund (Neuberger Berman Mid Cap Growth Fund Investor Class) is managed by Neuberger Berman with $460.6M in net assets. NMANX expense ratio is 0.83%, holding 76 positions across sectors including Industrials, Information Technology, Health Care. Inception date: 1979-03-01.

NMANX performance shows a YTD return of 9.77%. The 1-year return is -12.53% and the 5-year return is 1.66%. NMANX dividend yield stands at 20.63%, paid annually.

NMANX top holdings include Cencora Inc (4.2%), Hilton Worldwide Holdings, Inc. (3.8%), Howmet Aerospace Inc. (3.7%), Vertiv Group Corp (3.7%), Royal Caribbean Cruises Ltd. (3.2%). View all NMANX holdings, sector breakdown, or dividend history.

NMANX can be compared against other funds using the overlap calculator or side-by-side comparison tool. NMANX alternatives are available via the screener, along with tax-loss harvesting opportunities.